These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 26892546)
1. Antibacterials: A sweet vaccine. Bundle D Nat Chem; 2016 Mar; 8(3):201-2. PubMed ID: 26892546 [No Abstract] [Full Text] [Related]
2. An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2. Kong L; Vijayakrishnan B; Kowarik M; Park J; Zakharova AN; Neiwert L; Faridmoayer A; Davis BG Nat Chem; 2016 Mar; 8(3):242-9. PubMed ID: 26892556 [TBL] [Abstract][Full Text] [Related]
3. Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain. Altman E; Chandan V; Harrison BA; Veloso-Pita R; Li J; KuoLee R; Chen W; Vérez-Bencomo V; Vaccine; 2012 Nov; 30(50):7332-41. PubMed ID: 22534169 [TBL] [Abstract][Full Text] [Related]
4. Strategies in the Design and Use of Synthetic "Internal Glycan" Vaccines. Lakshminarayanan A; Vijayakrishnan B; Bayley H; Davis BG Methods Enzymol; 2017; 597():335-357. PubMed ID: 28935110 [TBL] [Abstract][Full Text] [Related]
5. Structural and immunological characterization of a glycoconjugate based on the delipidated lipopolysaccharide from a nontypeable Helicobacter pylori strain PJ1 containing an extended d-glycero-d-manno-heptan. Altman E; Chandan V; Harrison BA; Vinogradov E Carbohydr Res; 2018 Feb; 456():19-23. PubMed ID: 29247909 [TBL] [Abstract][Full Text] [Related]
10. Glycoconjugates enhanced the intracellular killing of Bacillus spores, increasing macrophage viability and activation. Tarasenko O; Soderberg L; Hester K; Park Kim M; McManus D; Alusta P Arch Microbiol; 2008 Jun; 189(6):579-87. PubMed ID: 18270686 [TBL] [Abstract][Full Text] [Related]
11. Crucial roles of charged saccharide moieties in survival of gram negative bacteria against protamine revealed by combination of grazing incidence x-ray structural characterizations and Monte Carlo simulations. Oliveira RG; Schneck E; Quinn BE; Konovalov OV; Brandenburg K; Gutsmann T; Gill T; Hanna CB; Pink DA; Tanaka M Phys Rev E Stat Nonlin Soft Matter Phys; 2010 Apr; 81(4 Pt 1):041901. PubMed ID: 20481747 [TBL] [Abstract][Full Text] [Related]
12. A study of different buffers to maximize viability of an oral Shigella vaccine. Chandrasekaran L; Lal M; Van De Verg LL; Venkatesan MM Vaccine; 2015 Nov; 33(46):6156-60. PubMed ID: 26428454 [TBL] [Abstract][Full Text] [Related]
13. Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine era. Albitar-Nehme S; Basheer SM; Njamkepo E; Brisson JR; Guiso N; Caroff M Carbohydr Res; 2013 Aug; 378():56-62. PubMed ID: 23731797 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines. Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633 [TBL] [Abstract][Full Text] [Related]
19. Molecular recognition of Brucella A and M antigens dissected by synthetic oligosaccharide glycoconjugates leads to a disaccharide diagnostic for brucellosis. Ganesh NV; Sadowska JM; Sarkar S; Howells L; McGiven J; Bundle DR J Am Chem Soc; 2014 Nov; 136(46):16260-9. PubMed ID: 25263136 [TBL] [Abstract][Full Text] [Related]
20. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease. Wright K; Guerreiro C; Laurent I; Baleux F; Mulard LA Org Biomol Chem; 2004 May; 2(10):1518-27. PubMed ID: 15136809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]